Allison L. Welter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allison L. Welter has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Anh T. Q. Cong
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication - Benoît Bragantini
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication - Gaofeng Cui
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication - Georges Mer
Mayo Clinic
1 shared publication - Julia R. Alvey
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication - Maria Victoria Botuyan
Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, USA
1 shared publication
Latest Publications
- Open Access
- 7 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes
FAM111A, a serine protease, plays roles in DNA replication and antiviral defense. Missense mutations in the catalytic domain cause hyper-autocleavage and are associated with genetic disorders with developmental defects. Despite the enzyme’s biological significance, the molecular architecture of the FAM111A serine protease domain (SPD) is unknown. Here, we show that FAM111A is a dimerization-dependent protease containing a narrow, recessed active site that cleaves substrates with a chymotrypsin-like specificity. X-ray crystal structures and mutagenesis studies reveal that FAM111A dimerizes via the N-terminal helix within the SPD. This dimerization induces an activation cascade from the dimerization sensor loop to the oxyanion hole through disorder-to-order transitions. Dimerization is essential for proteolytic activity in vitro and for facilitating DNA replication at DNA-protein crosslink obstacles in cells, while it is dispensable for autocleavage. These findings underscore the role of dimerization in FAM111A’s function and highlight the distinction in its dimerization dependency between substrate cleavage and autocleavage.
- 7 March 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-16
Open AccessDimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes
FAM111A, a serine protease, plays roles in DNA replication and antiviral defense. Missense mutations in the catalytic domain cause hyper-autocleavage and are associated with genetic disorders with developmental defects. Despite the enzyme’s biological significance, the molecular architecture of the FAM111A serine protease domain (SPD) is unknown. Here, we show that FAM111A is a dimerization-dependent protease containing a narrow, recessed active site that cleaves substrates with a chymotrypsin-like specificity. X-ray crystal structures and mutagenesis studies reveal that FAM111A dimerizes via the N-terminal helix within the SPD. This dimerization induces an activation cascade from the dimerization sensor loop to the oxyanion hole through disorder-to-order transitions. Dimerization is essential for proteolytic activity in vitro and for facilitating DNA replication at DNA-protein crosslink obstacles in cells, while it is dispensable for autocleavage. These findings underscore the role of dimerization in FAM111A’s function and highlight the distinction in its dimerization dependency between substrate cleavage and autocleavage.